A comprehensive medical review published in The Lancet examines current advances in treating autosomal dominant polycystic kidney disease (ADPKD), described as the most common genetic cause of chronic kidney disease worldwide. The condition results in substantial morbidity and mortality globally, according to the research.
Recent developments in molecular genetics and advanced imaging techniques have improved how doctors diagnose and predict the progression of ADPKD. These technological advances allow for more precise assessment of the disease's development and help clinicians better understand patient outcomes.